Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77,331,078
-
Total 13F shares
-
76,288,487
-
Share change
-
+769,106
-
Total reported value
-
$2,990,360,179
-
Put/Call ratio
-
2%
-
Price per share
-
$39.20
-
Number of holders
-
208
-
Value change
-
+$29,951,117
-
Number of buys
-
88
-
Number of sells
-
88
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q4 2024
As of 31 Dec 2024,
Xenon Pharmaceuticals Inc. - Common Stock (XENE) was held by
208 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
76,288,487 shares.
The largest 10 holders included
FMR LLC, Avoro Capital Advisors LLC, Driehaus Capital Management LLC, WELLINGTON MANAGEMENT GROUP LLP, BRAIDWELL LP, JANUS HENDERSON GROUP PLC, COMMODORE CAPITAL LP, Polar Capital Holdings Plc, Capital International Investors, and Capital World Investors.
This page lists
209
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.